The estimation of nondisplaceable binding from cerebellar white matter, rather than from whole cerebellum, was proposed for the PET tracer carbonyl-11 C-WAY-100635 (N-f2-[4-(2-methoxyphenyl)-1-piperazinyl]ethylg-N-(2-pyridyl)cyclohexanecarboxamidel]) because of the heterogeneity of total ligand binding in this region. For the 5-hydroxytryptamine receptor 1A (5-HT 1A ) antagonist 18 F-N-f2-[4-(2-methoxyphenyl)piperazin-1-yl]ethylg-N-2-pyridyl)trans-4-fluorocyclohexanecarboxamide ( 18 F-FCWAY), the estimation of nondisplaceable binding from cerebellum (V ND ) may be additionally biased by spillover of 18 F-fluoride activity from skull. We aimed to assess the effect of using cerebral white matter as reference region on detection of group differences in 5-HT 1A binding with PET and 18 F-FCWAY. Methods: In 22 temporal lobe epilepsy patients (TLE) and 10 healthy controls, 18 F-FCWAY distribution volume in cerebral white matter (V WM ) was computed using an extrapolation method as part of a partial-volume correction (PVC) algorithm. To assess the feasibility of applying this method to clinical studies in which PVC is not performed, V WM was also calculated by placing circular, 6-mm-diameter regions of interest (ROIs) in the centrum semiovalis on parametric images. Binding potentials were BP F 5 (V T -V ND )/f P and BP F-WM 5 (V T -V WM )/f P , where V T is total distribution volume and f P 5 18 F-FCWAY plasma free fraction. Statistical analysis was performed using t tests and linear regression. Results: In the whole group, V WM was 14% 6 19% lower than V ND (P , 0.05). V WM /f P was significantly (P , 0.05) lower in patients than in controls. All significant (P , 0.05) reductions of 5-HT 1A receptor availability in TLE patients detected by BP F were also detected using BP F-WM . Significant (P , 0.05) reductions of 5-HT 1A specific binding were detected by BP F-WM , but not BP F , in ipsilateral inferior temporal cortex, contralateral fusiform gyrus, and contralateral amygdala. However, effect sizes were similar for BP F-WM and BP F . The value of V WM calculated with the ROI approach did not significantly (P . 0.05) differ from that calculated with the extrapolation approach (0.67 6 0.32 mL/mL and 0.72 6 0.34 mL/mL, respectively). Conclusion: Cerebral white matter can be used for the quantification of nondisplaceable binding of 5-HT 1A without loss of statistical power for detection of regional group differences. The ROI approach is a good compromise between computational complexity and sensitivity to spillover of activity, and it appears suitable to studies in which PVC is not performed. For 18 F-FCWAY, this approach has the advantage of avoiding spillover of 18 F-fluoride activity onto the reference region.
PETst udies of serotonergic 5-hydroxytryptamine receptor 1A (5-HT 1A ) are of interest in several neuropsychiatric disorders. Carbonyl-11 C-WAY-100635 and 18 F-N-f2-[4-(2-methoxyphenyl)piperazin-1-yl]ethylg-N-2-pyridyl)trans-4-fluorocyclohexanecarboxamide ( 18 F-FCWAY) are frequently used for quantitative measurements with PET of 5-HT 1A receptor specific binding. Quantification of the binding potential requires the estimation of nondisplaceable (free plus nonspecific) binding. Autoradiographic studies showed that, among gray matter regions, 5-HT 1A receptor concentration was lowest in the cerebellum (1, 2) . Therefore, this region traditionally has been used for the estimation of nondisplaceable binding for 5-HT 1A tracers.
More recently, PET studies with carbonyl-11 C-WAY-100635 indicated a significant concentration of 5-HT 1A in cerebellar vermis and cortex of adult subjects and suggested that cerebellar white matter could be a better reference region for the estimation of nondisplaceable binding (3, 4) . The potential advantage of using cerebellar white matter has been addressed in a limited number of studies (3) (4) (5) .
The possibility of using a reference region other than the cerebellum is of particular interest for the 5-HT 1A tracer 18 F-FCWAY (6) . After intravenous injection, this tracer rapidly undergoes defluorination to 18 F-fluoride, which irreversibly accumulates in the skull (7) , causing substantial spillover of activity into the neighboring brain tissue. Despite the development of a correction strategy (8, 9) , tissue counts can be biased, especially in low-binding regions such as the cerebellum. Therefore, regions of interest (ROIs) have been drawn far from the cortical rim to avoid bias in binding potential measurement (10) .
On the basis of results obtained for carbonyl-11 C-WAY-100635 with cerebellar white matter and because of the distance of the centrum semiovalis from the extracerebral 18 F-fluoride activity, we hypothesized that cerebral white matter could be a valid alternative to the cerebellum for the estimation of nondisplaceable binding for 18 F-FCWAY. The aim of this study was to assess the impact on detection of differences in 5-HT 1A receptor availability between temporal lobe epilepsy (TLE) patients and healthy controls using 18 F-FCWAY binding in cerebral white matter as an estimate of nondisplaceable binding. The regional pattern of group differences obtained using the cerebellum was previously reported (10) .
MATERIALS AND METHODS

Patient Selection
Data from 22 TLE patients (18 men; mean age 6 SD, 37 6 11 y) and 10 healthy volunteers (7 men; mean age, 35 6 9 y) previously studied (10) were reexamined. Briefly, patients were referred for evaluation of medically refractory TLE. All patients were taking different combinations of antiepileptic drugs (10, 11) . None had experienced partial seizures for at least 2 d, or a secondarily generalized tonic clonic seizure for at least 1 mo, before PET studies. T1-weighted volumetric MR images were acquired for segmentation purposes, and T2-weighted and fluid-attenuated inversion recovery (FLAIR) images were obtained for the evaluation of mesial temporal sclerosis. The study was approved by the National Institute of Neurological Disorders and Stroke Institutional Review Board and the National Institutes of Health Radiation Safety Committee.
PET Procedure
Each patient was scanned with an Advance Tomograph (GE Healthcare). A bolus of 333 6 74 MBq of 18 F-FCWAY was injected intravenously, and dynamic scanning was performed for 120 min in 3-dimensional mode. Arterial samples were taken to quantify plasma 18 F-FCWAY and 18 F-fluorocyclohexanecarboxylic acid metabolite ( 18 F-FC) concentrations and whole-blood activity. The 18 F-FCWAY fraction unbound to plasma proteins was measured with ultracentrifugation (12) .
PET Data Analysis
Radioactivity frames registered to MR images (13) were corrected for cerebral uptake of acid radioactive metabolite, intravascular radioactivity, and 18 F-fluoride spillover onto the brain (8, 9) . The method to correct for 18 F-fluoride spillover assumes that there is a known true skull time-activity curve, and each brain region receives a fractional contribution of this time-activity curve that is higher for areas that are closer to the skull (8, 9) . Next, a previously developed partial-volume correction (PVC) algorithm (10, 14) was applied. Briefly, the PVC algorithm corrects on a frame-by-frame basis gray matter pixels for spill-out of gray matter activity and for spill-in of activity from white matter (15) . No correction for partial-volume averaging between adjacent gray matter regions is performed (16, 17) . The procedure is based on the segmentation of MR images into binary masks (18) , which are subsequently smoothed to the PET resolution; these smoothed masks are named s GM , s WM , and s CSF . The corrected activity gray matter values can be calculated as follows: (15, 19) , but the effect is expected to be more important if white matter is used as the estimate of nondisplaceable binding. An anatomic constraint was applied to avoid sampling from the basal ganglia and thalamus, in which gray matter is frequently misidentified as white matter (14) . Values of these pixels were then fitted as a linear function of s WM , and the fitted value at s WM 5 1 was used as an estimate of nondisplaceable binding.
The extrapolation method is used for studies in which PVC is performed. To assess the feasibility of using white matter for more routine clinical studies without PVC, V WM was also calculated with an ROI procedure on parametric PET images. First, 3 contiguous transverse slices for which the centrum semiovalis displayed minimal activity were identified. Next, a 6-mm ROI was centered on the area of lowest signal in both hemispheres. This operation was performed on each identified slice, using a total of 6 ROIs. The mean pixel value was calculated in each ROI, and the 6 regional values were averaged to obtain V WM .
Derivation of Binding Potential
Binding potentials were derived using both V ND and V WM , as following:
Eq. 2
where V T is the total distribution volume in the target ROI, V ND is the distribution volume in the cerebellum, and f P is 18 F-FCWAY plasma free fraction (20) .
ROI Analysis
Temporal and extratemporal ROIs were drawn on MR images and applied to coregistered parametric images (10) . Cerebellar ROIs were initially drawn along the outer cortical edge, then uniformly shrunk until, on visual inspection, no spillover of activity was observed. Final cerebellar ROIs were about 50% jnm063743-pm n 10/13/09 smaller than original ROIs (10) . ROI measurements were computed using only gray matter pixels, as defined by the gray matter segment (18) . For the cerebellum, for which gray matter segment definition is not accurate, the mean ROI value was computed from unmasked PET images coregistered to MRI volumes (10) . The effect size was computed as the difference between patients and controls divided by the SD in the control group. Statistical analysis was performed using t test and linear regression, and statistical significance was set at uncorrected P , 0.05.
RESULTS
½Fig: 1 Figure 1 shows transverse images of 18 F-FCWAY distribution volume in a TLE patient. In the cerebellum, the large spillover of 18 F-fluoride activity masks the visualization of possible differences in specific binding between gray and white matter. At the cortical level, there is a clear difference in 18 F-FCWAY binding between centrum semiovalis white matter and gray matter or mixed gray matter-white matter regions. Spillover of 18 F-fluoride activity is observed in the left frontal and bilateral parietal cortex. ½Fig: 2 Figure 2 shows representative time-activity curves from a healthy control. In white matter, activity peaked at about 5 min after injection, then progressively decreased to 57%, 24%, and 21% of peak at 30, 60, and 120 min, respectively. The activity peak in white matter was about 40% lower than that in cerebellum. White matter and cerebellar timeactivity curves overlapped, starting from about 25 min after injection. As expected, in both regions the time-activity curve was markedly different from the time-activity curve of the mesial temporal cortex.
½Fig: 3 Figure 3 shows the extrapolation method used to automatically estimate V WM , as part of the PVC process. On the distribution volume images, values of voxels with smoothed white matter mask s WM between 0.986 and 0.995 were fitted to a straight line, and the extrapolated value for s WM 5 1 was taken as an estimate of nondisplaceable binding. The volume of white matter voxels with an s WM between 0.986 and 0.995 was 19 6 5 mL. The quality of fit, as quantified by r 2 values, was good in the whole sample (r 2 5 0.88 6 0.11; range, 0.59-0.99). FIGURE 1. Transverse MR and 18 F-FCWAY distribution volume images passing through centrum semiovalis and cerebellum in TLE patient. Negligible binding of tracer in cerebellar white matter and centrum semiovalis and large spillover of 18 F-fluoride activity onto cerebellum were observed. Two 6-mm-diameter, circular ROIs used for calculation of V WM with manual approach are displayed. 18 F-FCWAY distribution volume image (V/f P ) is scaled to maximum of 80 mL/mL. RGB FIGURE 2. Representative time-activity curves from healthy control for white matter (s, 1.9 cm 2 ), cerebellum (:, 4.2 cm 2 ), and mesial temporal cortex ( , 2.8 cm 2 ). jnm063743-pm n 10/13/09
In
). The percentage difference between V WM and V ND was 14% 6 19%, without significant (P . 0.05) differences between TLE patients and controls. On a subject-by-subject basis, V WM was lower or of the same magnitude as V ND in all but 3 subjects, in whom V WM was 11%, 14%, and 29% higher than V ND . A significant relationship was found between V WM and V ND (regression equation Fig. 4 ). V WM was significantly (P , 0.05) higher in patients than in controls (0.81 6 0.35 mL/mL and 0.55 6 0.25 mL/mL, respectively). 18 F-FCWAY f P was significantly higher in patients than in controls (0.121 6 0.033 vs. 0.066 6 0.024, respectively; P , 0.05), a finding that may be attributed to antiepileptic drugs (10, 11) . V WM /f P , however, was significantly (P , 0.05) lower in patients than in controls (6.80 6 2.56 mL/mL and 9.32 6 3.16 mL/mL, respectively).
The variability of V WM , as quantified by the percentage coefficient of variation (%CV), was greater than that of V ND (45.2% vs. 39.5% in controls and 43.0% vs. 31.6% in patients, respectively). Nevertheless, the variability of BP F-WM was not significantly higher (P . 0.05) than that of BP F , respectively. In the whole group, mean values of %CV across ROIs were 36.8% 6 5.6 and 35.5% 6 6.0, respectively, for BP F and BP F-WM . All significant differences detected using BP F (10) were also detected using BP F-WM . Significantly (P , 0.05) lower BP F-WM , but not BP F , was detected in ipsilateral inferior temporal cortex, contralateral fusiform gyrus, and contralateral amygdala. However, effect sizes were similar for BP F-WM and BP F ( ½Table 1  Table 1 ). In the whole group, values of V WM calculated with the ROI approach did not significantly differ from those obtained with the extrapolation technique (0.67 6 0.32 mL/mL and 0.72 6 0.34 mL/mL, respectively; P . 0.05). Group differences in specific binding were detected without any regional discrepancy in comparison to those detected with the extrapolation approach.
DISCUSSION
The cerebellum has been used in several PET studies to estimate nondisplaceable binding of 5-HT 1A . However, for both carbonyl-11 C-WAY-100635 (21-23) and 18 F-FCWAY (8), a 2-compartment model was necessary to accurately fit cerebellar time-activity curves. This finding was attributed to a slow component of nondisplaceable binding or to the progressive accumulation of radioactive metabolites (8, (21) (22) (23) . This unexpected finding motivated the search for nontraditional reference regions for the estimation of nondisplaceable binding.
Using PET with carbonyl-11 C-WAY-100635, Parsey et al. found that cerebellar white matter time-activity curves were well described by a 1-tissue-compartment model (3). Using cerebellar white matter, rather than the whole cerebellum, for the derivation of the binding potential improved the identifiability and time stability in all cortical regions. The authors concluded that for carbonyl-11 C-WAY-100635, cerebellar white matter could be a better reference region than the whole cerebellum (3).
For 18 F-FCWAY, the estimation of nondisplaceable binding from the cerebellum has the additional problem of spillover of 18 F-fluoride activity. This applies to the cortex as well, even though specific binding is high in cortical regions. A method to correct for such spillover was developed. This method, however, does not accurately take into account intersubject variations in the skull shape and thickness (8, 9) . Disulfiram was used to inhibit defluorination of 18 F-FCWAY in humans (24) . The drug reduced the accumulation of 18 F-fluoride in the skull and improved the visualization of radioligand cerebral binding. However, disulfiram also affected the clearance of 18 F-FCWAY and acid radioactive metabolite and jeopardized the accuracy of the compartmental analysis (24) .
A simple approach to minimize the effect of 18 F-fluoride spillover onto the cerebellum is to draw ROIs far from the cerebellar edge (10) . However, some residual spillover from the bone or mixing of regions with different 5-HT 1A receptor concentrations cannot be excluded. Alternatively, a different reference region could be identified.
Suitability of Cerebral White Matter for Quantification of 18 F-FCWAY Nondisplaceable Binding
The suitability of a region to provide an estimate of nondisplaceable binding can be inferred from kinetic jnm063743-pm n 10/13/09 analysis or preblocking studies. Adequate fitting with a 1-tissue-compartment model and negligible k 3 and k 4 values are consistent with a lack of significant concentration of specific receptors. In preblocking studies, the baseline regional distribution volume is compared with that obtained after the administration of a specific receptor cold ligand. If a region is truly devoid of specific binding, the regional value should be comparable in the 2 conditions. Carson et al. performed preblocking 18 F-FCWAY PET studies in monkeys (8) . The administration of unlabelled WAY-100635 in advance produced a significant reduction in total binding in the cerebellum by about 44%. This result is inconsistent with the assumption that the cerebellum is a region with only nondisplaceable binding sites for 18 F-FCWAY. Unfortunately, changes of the distribution volumes in white matter were not evaluated (8) . Admittedly, the lack of preblocking studies and of formal kinetic analysis, that is, analysis of goodness of fit and calculation of rate constants, represents a significant limit of this study.
Cerebral white matter would be expected to be suitable for the quantification of nondisplaceable binding. White matter is composed of bundles of myelinated axons. The myelin sheath, which is produced by glial cells, is a bimolecular layer of lipids interspersed between protein layers. No significant expression of 5-HT 1A or receptor messenger RNA was found in glial cells (25) (26) (27) .
Visual inspection of both carbonyl-11 C-WAY-100635 (3,28) and 18 F-FCWAY (8, 10, 24) images shows low activity in the centrum semiovalis.
Finally, starting from about 25 min after the injection of 18 F-FCWAY, the cerebral white matter time-activity curve is similar to the cerebellar time-activity curve, and both time-activity curves have characteristics consistent with negligible concentration of specific binding sites, compared with the cortex.
Group Differences Using White Matter
We failed to show a substantial gain in statistical power using white matter. In TLE patients, lower 5-HT 1A receptor specific binding was detected in ipsilateral inferior temporal cortex, contralateral fusiform gyrus, and contralateral amygdala using V WM but not V ND (Table 1) . However, by comparing P values and effect sizes, it is evident that the lack of significant group differences in these regions using BP F (10) is likely a false-negative finding. These results are not unexpected given that regional values of specific binding are much greater than those of nondisplaceable binding, independently of the reference region. Our findings are consistent with results obtained with carbonyl-11 C-WAY-100635, indicating no substantial advantage in the detection of sex differences in the hippocampus using BP F-WM , compared with using BP F (3).
Comparison Between V WM and V ND We found lower V WM than V ND . Although this difference was statistically significant, the magnitude of the difference (14%) was low, and several factors could contribute to this finding. Admittedly, smaller 18 F-FCWAY distribution volume in white matter per se does not constitute evidence of jnm063743-pm n 10/13/09 less specific binding. Because of the low parent accumulation in these regions, differences in radioligand delivery, blood volume, radiometabolite accumulation, spillover of 18 F-fluoride onto the cerebellum, and partial-volume averaging could contribute to this difference. The lower peak of the white matter time-activity curve than of the cerebellar time-activity curve likely reflects lower flow-mediated radioligand delivery. The lower peak of the cerebellar white matter time-activity curve than of the whole cerebellum time-activity curve was reported by Parsey et al. (3) and by Hirvonen et al. (4) . Starting from about 25 min after injection, the 2 time-activity curves had similar height and time dependence.
Group Differences in Nondisplaceable Binding
The absence of significant group differences in nondisplaceable binding is a prerequisite for determining that measured differences of interest reflect only specific binding. Such differences can be assessed only in arterial linebased models, which are now favored less than less invasive reference tissue models (21, (29) (30) (31) (32) . However, when arterial line-based models were used, significant group differences in nondisplaceable binding with 5-HT 1A tracers were reported. A higher V ND (not corrected for f p ) was found in healthy women than in healthy men (3, 33) , whereas a lower uncorrected V ND was found in depressed patients than in healthy controls (5) . A lower V ND , after correction for f p , was previously reported in these TLE patients (10, 11) . If a region is devoid of specific binding and f p drives the kinetics of the tracer, group differences in nondisplaceable binding estimates might be expected in values uncorrected for f p , but they should be canceled out after f p correction. These group differences could be attributed to actual differences in 5-HT 1A receptor availability, nondisplaceable binding, blood volume, or acid corrections. For 18 F-FCWAY, an additional artificial cause might be the spillover of 18 F-fluoride activity.
Choice of Binding Outcome
Previous PET studies with carbonyl-11 C-WAY-100635 found that BP F is the most sensitive binding outcome for the accurate quantification of 5-HT 1A receptor availability (3, 5, 23, 33) . On the basis of this finding and to account for group differences in V ND , we had chosen BP F as primary binding outcome (10, 11) . For 18 F-FCWAY, the magnitude of nondisplaceable binding is small, as evidenced by the low value of V ND or V WM , compared with V T , in cortical and limbic areas. Thus, V T primarily reflects specific binding. In this sample, regional group differences detected with BP F were similar to those detected with V T /f p without significant loss of statistical power (data not shown). Thus, if spillover of 18 F-fluoride onto the cerebellum is a concern and scientific evidence supporting the use of white matter as an estimate of nondisplaceable binding is not sufficient, the small group differences in nondisplaceable binding could be neglected and V T /f p could be used as primary binding outcome in future studies in TLE patients with 18 F-FCWAY (34) .
Variability of V WM
The variability of V WM was higher than that of V ND . Comparable %CV for cerebellar white matter and whole cerebellum was detected by both Parsey et al. (3, 33) and Hirvonen et al. (4) . Because of the higher specific binding of cortical regions and large interregion variability, ultimately no variability is added to 18 F-FCWAY binding potential measurements.
Cerebellum and TLE
In TLE patients, the use of cerebral white matter as reference region may be preferable because of cerebellar atrophy. Epilepsy itself-and some antiepileptic drugs, particularly phenytoin-may induce cerebellar structural change and hypometabolism on 18 F-FDG PET (35, 36) . These effects may be more severe in patients with long epilepsy duration and uncontrolled seizures, who are most likely to have PET studies (35) . Moreover, changes in 5-HT concentration in the cerebellum have been reported because of antiepileptic drugs and the effects of uncontrolled epilepsy itself (37) .
CONCLUSION
Using cerebral white matter, rather than the cerebellum, as an estimate of 18 F-FCWAY nondisplaceable binding, we found regional reductions of 5-HT 1A receptor specific binding in TLE patients, without loss of statistical power. These findings add to results obtained with carbonyl-11 C-WAY-100635 that support the use of white matter for the estimation of nondisplaceable binding for 5-HT 1A tracers in clinical studies and expand the emerging topic of nontraditional reference regions.
